Thank you, Mr. Chair. As always, I appreciate the opportunity for expanded written results and responses.
Through you to the subject matter expert whom we have here today, Dr. El Emam, I welcome him to the committee. I certainly want to acknowledge how much of this is new to me and, I'm sure, many of our colleagues in terms of the very highly technical nature of technology and where we are at right now with big data.
I'm going to rely on you to hopefully help us unpack this and explain it to me like I'm five years old. If you've already answered this question, I'd ask that you try to simplify it even more. In last week's presentations, I'm sure you'll recall that there was very specific language used around anonymized and de-identified data...and of course, from my perspective, the ability to hopefully get to some really solid recommendations from this committee to create gold standards internationally on having some of the highest rights-based approaches to data.
First, through the chair to the good doctor, given your role with Replica Analytics, do you work with countries internationally, around the world, on the emerging technology that you have created?